Talk:Ataluren

This is the talk page for discussing improvements to the Ataluren article.
This is not a forum for general discussion of the article's subject.

Put new text under old text. Click here to start a new topic.
New to Wikipedia? Welcome! Learn to edit; get help.

Article policies

Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL

Chemicals Low‑importance

	This article is within the scope of WikiProject Chemicals, a daughter project of WikiProject Chemistry, which aims to improve Wikipedia's coverage of chemicals. To participate, help improve this article or visit the project page for details on the project.ChemicalsWikipedia:WikiProject ChemicalsTemplate:WikiProject Chemicalschemicals articles
Low	This article has been rated as Low-importance on the project's importance scale.

Molecular Biology: Genetics

	This article is within the scope of WikiProject Molecular Biology, a collaborative effort to improve the coverage of Molecular Biology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.Molecular BiologyWikipedia:WikiProject Molecular BiologyTemplate:WikiProject Molecular BiologyMolecular Biology articles
???	This article has not yet received a rating on the importance scale.
	This article is supported by the Genetics task force (assessed as Low-importance).

Pharmacology Mid‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Medicine Mid‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Ataluren.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

Old talk[edit]

perhaps ptc-124 and ptc 124 should forward here to make search engine finds easier.Mkayatta 23:06, 9 November 2007 (UTC)[reply]

Both search terms give this page as their first results. --ἀνυπόδητος (talk) 14:09, 23 July 2015 (UTC)[reply]

2016[edit]

The CAS number as written is correct, and can be verified at the NCBI PubChem site. It points to Ataluren. Unfortunately, I don't yet know how to change that red X to the green check mark in the right sidebar (Chembox?) of the Wiki article. Suirauqa (talk) 19:26, 5 October 2016 (UTC)[reply]

2017[edit]

This entire page is wildly misleading an propagates the myth of Ataluren as a drug that affects read through. It is actually a compound that binds and stabilizes firefly luciferase, creating the impression that more of this luciferase is being made. I have personally seen it raise the signal in a screen I am doing in which the increase in luciferase would be associated with transcription in a yeast cell, not translation in a mammalian cell (the screen for which Ataluren was developed).Hoffmacs (talk) 11:44, 28 November 2017 (UTC)[reply]